| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 152, 341-345, Copyright © 1998 by American Society for Investigative Pathology
REGULAR ARTICLES |
D Nehrbass, F Klimek and P Bannasch
Abteilung fur Cytopathologie, Deutsches Krebsforschungszentrum Im Neuenheimer Feld, Heidelberg, Germany.
Insulin receptor substrate-1 (IRS-1) is a multisite docking protein occupying a central position in signaling cascades stimulated by a number of growth factors including insulin. Using Western blotting and immunohistochemistry, we investigated the expression of IRS-1 in more than 400 preneoplastic foci of altered hepatocytes and in 12 hepatocellular carcinomas induced in rats by oral administration of N- nitrosomorpholine. In both N-nitrosomorpholine-treated and untreated rat livers, IRS-1 was demonstrable by Western blotting, but with the exception of a few single hepatocytes it was not detectable in the normal parenchyma by immunohistochemistry. In contrast, immunohistochemistry revealed that IRS-1 was strongly expressed in the majority of foci of altered hepatocytes particularly in approximately 97% of the clear/acidophilic and mixed cell foci showing excessive storage of glycogen (glycogenosis). In glycogen-poor basophilic foci of altered hepatocytes and hepatocellular carcinomas, IRS-1 was not detected by immunohistochemistry, but a weak expression was observed in small subpopulations of three hepatocellular carcinomas containing remnants of glycogen. These results indicate that the focal overexpression of IRS-1 is an early event in hepatocarcinogenesis, which is closely correlated with preneoplastic hepatic glycogenosis. During progression from glycogenotic foci to hepatocellular carcinomas, IRS-1-overexpression is gradually down-regulated, and this late event is associated with a fundamental metabolic shift leading to the malignant neoplastic phenotype.
This article has been cited by other articles:
![]() |
R. K. Dearth, X. Cui, H.-J. Kim, I. Kuiatse, N. A. Lawrence, X. Zhang, J. Divisova, O. L. Britton, S. Mohsin, D. C. Allred, et al. Mammary Tumorigenesis and Metastasis Caused by Overexpression of Insulin Receptor Substrate 1 (IRS-1) or IRS-2 Mol. Cell. Biol., December 15, 2006; 26(24): 9302 - 9314. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Dombrowski, C. Mathieu, and M. Evert Hepatocellular Neoplasms Induced by Low-Number Pancreatic Islet Transplants in Autoimmune Diabetic BB/Pfd Rats Cancer Res., February 1, 2006; 66(3): 1833 - 1843. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Boissan, E. Beurel, D. Wendum, C. Rey, Y. Lecluse, C. Housset, M.-L. Lacombe, and C. Desbois-Mouthon Overexpression of Insulin Receptor Substrate-2 in Human and Murine Hepatocellular Carcinoma Am. J. Pathol., September 1, 2005; 167(3): 869 - 877. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Dombrowski, C. M. Jost, S. Manekeller, and M. Evert Cocarcinogenic Effects of Islet Hormones and N-Nitrosomorpholine in Hepatocarcinogenesis after Intrahepatic Transplantation of Pancreatic Islets in Streptozotocin-Diabetic Rats Cancer Res., August 1, 2005; 65(15): 7013 - 7022. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Evert, J. Sun, S. Pichler, N. Slavova, R. Schneider-Stock, and F. Dombrowski Insulin Receptor, Insulin Receptor Substrate-1, Raf-1, and Mek-1 during Hormonal Hepatocarcinogenesis by Intrahepatic Pancreatic Islet Transplantation in Diabetic Rats Cancer Res., November 1, 2004; 64(21): 8093 - 8100. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mayer, K. Forstner, and K. Kopplow Induction and Modulation of Hepatic Preneoplasia and Neoplasia in the Rat by Dehydroepiandrosterone Toxicol Pathol, January 1, 2003; 31(1): 103 - 112. [Abstract] [PDF] |
||||
![]() |
Qin Su and P. Bannasch Relevance of Hepatic Preneoplasia for Human Hepatocarcinogenesis Toxicol Pathol, January 1, 2003; 31(1): 126 - 133. [Abstract] [PDF] |
||||
![]() |
A. Lassak, L. Del Valle, F. Peruzzi, J. Y. Wang, S. Enam, S. Croul, K. Khalili, and K. Reiss Insulin Receptor Substrate 1 Translocation to the Nucleus by the Human JC Virus T-antigen J. Biol. Chem., May 3, 2002; 277(19): 17231 - 17238. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |